Dang L - Search Results

1

Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments.

Zhang X, Fryknäs M, Hernlund E, Fayad W, De Milito A, Olofsson MH, Gogvadze V, Dang L, Påhlman S, Schughart LA, Rickardson L, D'Arcy P, Gullbo J, Nygren P, Larsson R, Linder S. Zhang X, et al. Among authors: dang l. Nat Commun. 2014;5:3295. doi: 10.1038/ncomms4295. Nat Commun. 2014. PMID: 24548894 Free PMC article.

2

Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake.

Ko SY, Lee W, Kenny HA, Dang LH, Ellis LM, Jonasch E, Lengyel E, Naora H. Ko SY, et al. Commun Biol. 2019 Oct 18;2:386. doi: 10.1038/s42003-019-0609-x. eCollection 2019. Commun Biol. 2019. PMID: 31646189 Free PMC article.

3

Targeting both HIF-1 and HIF-2 in human colon cancer cells improves tumor response to sunitinib treatment.

Burkitt K, Chun SY, Dang DT, Dang LH. Burkitt K, et al. Mol Cancer Ther. 2009 May;8(5):1148-56. doi: 10.1158/1535-7163.MCT-08-0944. Epub 2009 May 12. Mol Cancer Ther. 2009. PMID: 19435875

4

Combination therapy targeting cancer metabolism.

Wenger JB, Chun SY, Dang DT, Luesch H, Dang LH. Wenger JB, et al. Med Hypotheses. 2011 Feb;76(2):169-72. doi: 10.1016/j.mehy.2010.09.008. Epub 2010 Oct 13. Med Hypotheses. 2011. PMID: 20947261 Free PMC article. Review.

5

Combination therapy for renal cell cancer: what are possible options?

Santos N, Wenger JB, Havre P, Liu Y, Dagan R, Imanirad I, Ivey AM, Zlotecki RA, Algood CB, Gilbert SM, Allegra CJ, Okunieff P, Vieweg J, Dang NH, Luesch H, Dang LH. Santos N, et al. Oncology. 2011;81(3-4):220-9. doi: 10.1159/000333470. Epub 2011 Nov 12. Oncology. 2011. PMID: 22085914 Free PMC article. Review.

6

Can we develop effective combination antiangiogenic therapy for patients with hepatocellular carcinoma?

Wenger JB, Santos N, Liu Y, Dallas J, Subbiah S, Hochwald S, Huang EH, Dang DT, Allegra CJ, Luesch H, Dang LH. Wenger JB, et al. Oncol Rev. 2011 Sep;5(3):177-184. doi: 10.1007/s12156-011-0082-3. Oncol Rev. 2011. PMID: 21949574 Free PMC article.

7

Focal adhesion kinase signaling and function in pancreatic cancer.

Ucar DA, Dang LH, Hochwald SN. Ucar DA, et al. Front Biosci (Elite Ed). 2011 Jan 1;3(2):750-6. doi: 10.2741/e283. Front Biosci (Elite Ed). 2011. PMID: 21196348 Free article. Review.

8

Intracrine vascular endothelial growth factor signaling in survival and chemoresistance of human colorectal cancer cells.

Samuel S, Fan F, Dang LH, Xia L, Gaur P, Ellis LM. Samuel S, et al. Among authors: dang lh. Oncogene. 2011 Mar 10;30(10):1205-12. doi: 10.1038/onc.2010.496. Epub 2010 Nov 8. Oncogene. 2011. PMID: 21057529 Free PMC article.

9

Glutathione S-transferase pi1 promotes tumorigenicity in HCT116 human colon cancer cells.

Dang DT, Chen F, Kohli M, Rago C, Cummins JM, Dang LH. Dang DT, et al. Cancer Res. 2005 Oct 15;65(20):9485-94. doi: 10.1158/0008-5472.CAN-05-1930. Cancer Res. 2005. PMID: 16230413

10

Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts.

Dang DT, Chen F, Gardner LB, Cummins JM, Rago C, Bunz F, Kantsevoy SV, Dang LH. Dang DT, et al. Cancer Res. 2006 Feb 1;66(3):1684-936. doi: 10.1158/0008-5472.CAN-05-2887. Cancer Res. 2006. PMID: 16452228

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,076 results

Search Page